Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP - Wikidata - awgldk - TriplyDB

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

http://www.wikidata.org/entity/Q35185929

about

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53 Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3 MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300.Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation Inhibition of p300/CBP by early B-cell factor Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells Acetyltransferases and tumour suppression Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia Development of anticancer agents targeting the Wnt/β-catenin signaling Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research Protein lysine acetylation by p300/CBP An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy p53 Acetylation: Regulation and Consequences The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5 Inactivating mutations of acetyltransferase genes in B-cell lymphoma CREB binding protein is required for both short-term and long-term memory formation.A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin.TLX1/HOX11-induced hematopoietic differentiation blockade.p53 targets simian virus 40 large T antigen for acetylation by CBP The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity.Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway.Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.Purification and characterization of recombinant CH3 domain fragment of the CREB-binding protein.The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo.Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity

P2860

Q24297284-A06A16D2-AD33-4ECD-A6C1-3A073817955B Q24306838-0D7F2F6F-BD37-4B2F-8B8F-8A5D3BF5C325 Q24317246-BC998CA6-5E08-4F02-971F-AD35CFC7BB8A Q24535750-0FB6D939-A04A-45BC-9778-511895C293BF Q24537650-EF2D3441-C50C-4F61-A035-579140474D33 Q24537722-9F5B2008-02DE-493D-96D5-9CFA2C390B45 Q24540319-E58104F0-480B-47CB-985D-1B66081222DC Q24555212-9F968536-811D-4A4E-8A14-65BD5CA3D028 Q24557551-07CC398F-6071-4274-96D3-0EE84129B2B6 Q24633440-B8C7A63C-8117-492D-918D-B3C43ECE19F8 Q24652801-28273174-BA4B-4305-9270-3A276343945D Q24672302-016AF75E-9B3C-4856-88AF-F3E94ADC2DCA Q24673236-0F4C640A-92A6-4058-B9CF-784039B7D748 Q24685650-8E6D0B5C-E800-4ECC-A5CE-454D440AFD91 Q24803177-33D5CD05-667A-4EAD-9B71-AD2328FD72FD Q26778780-7152F0A6-3FAE-4E67-8996-D8A5E76D0238 Q26781898-14D9759F-408D-4E82-BC20-DCDC4D7939EC Q26859843-B1504434-509E-4892-A129-3F1E71F4EEFD Q27021749-FA4843E2-A24A-40F9-B14B-2FF46CC0F47B Q27312434-D14F3C00-F6FC-46F8-B6A8-75D8BB00F382 Q27644535-928BBF17-D68D-4EEB-A4DA-2DCAF18E0F47 Q28082536-FA34CA57-3E9F-46E5-A4EE-D8CBD6741DBA Q28085076-0BF5B52B-7B0C-459E-B01E-625B5694DBE9 Q28088295-1FDD8E04-F10F-4F00-AD6E-46026CA47AA2 Q28269627-F6F695F2-B955-4688-8BA2-C2EAB1BB42F3 Q28536743-7C1A3A2B-3E37-469C-B9C1-0211CF152252 Q28590949-FE080DAA-72A1-41B4-898A-2C6459A3B880 Q28591430-A8A96828-B357-41AE-8E59-7A454FC22560 Q29031276-227C2B00-62A1-4FE4-8E7E-0EFC4CBAA0A3 Q30476167-FD2B36D3-1FEB-4F07-92B2-5CBBD10CF85B Q31106002-0B7FF82F-A3FF-468E-9A87-FD53BDFD927F Q33193939-C33EB177-A03F-431F-B1E1-29755688E962 Q33268741-AC075A01-C610-491D-90FB-32E884774517 Q33292247-00D9F99A-9BA8-48CE-BF69-DCD57ECEEC63 Q33419571-1F8DAB99-D76E-48D8-B1C3-B238D1F5FAE1 Q33709523-78FE13B7-A265-424D-8B33-2854637E2B52 Q33736104-35EC5D2E-FC2F-4FAC-BAFB-E048C7359432 Q33738185-C3BEF25E-520A-4461-AA7B-339CBE4698AB Q33913962-D98A563F-3329-4C80-9A4A-A9B5C6B2EF70 Q33948318-B1879D12-9D78-41E2-BC20-C422917B8422

P2860

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

http://www.wikidata.org/entity/Q35185929

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@ast

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@en

type

label

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@ast

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@en

prefLabel

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@ast

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@en

P1433

Q35185929-997E32A7-B983-4DAF-ADBE-84DCA09BE90C

P1476

Q35185929-9D900459-D05D-4487-90A7-D103AAB90C10

P2093

Q35185929-008C9068-584C-442B-952F-78FA3F3BF449

Q35185929-19B11234-37BE-41AB-A6CA-6D468CC9E6A2

Q35185929-38D0326B-8809-429F-9539-0158152E4FFB

Q35185929-3FCC8C19-9E26-4FF0-8B5F-2842332B16CD

Q35185929-55C21E50-0BC5-4204-A9DA-AF1EC3EF7A11

Q35185929-96C61C60-47A2-489C-B37B-93F5CA84E21F

Q35185929-EA190C94-C945-4996-800E-2274BFB0E6CD

P2860

Q35185929-193AD134-D2FE-44E8-91D8-49D7C7765C2F

Q35185929-1C8698F3-ABDA-4771-811E-B9F07AF05ED9

Q35185929-2833FB5A-B42D-4C1B-A2CD-A3636F6365D2

Q35185929-39F61821-369A-496A-ABB0-61FB3177D32F

Q35185929-40A8ACB6-949A-4589-9119-9F1D8E1A6EF5

Q35185929-4993F35E-457D-416E-BA9F-036AABBB724B

Q35185929-5178EFFC-00C9-48F9-AFA0-78B353FA567B

Q35185929-5FA83194-36A9-487A-9E2A-B918B9B45499

Q35185929-6974B7B0-3512-4E57-B348-2840D74A728B

Q35185929-780A82A9-FA38-4EFD-AB43-930DC49FAF55

P304

Q35185929-27C3C269-FCAF-4998-BEEF-2E367B93B72D

P31

Q35185929-6389DD41-FBFC-4389-B252-0A3B0D4A47A1

P433

Q35185929-0392E738-03F7-4816-B33D-1DA4EA247872

P478

Q35185929-AEAAD19C-C672-48A1-9BE2-0F6226511723

P577

Q35185929-DDA9B683-9E1F-4A0F-9C46-B62F2AAB3CDB

P698

Q35185929-02C62E3C-BC97-4D0D-BF3F-2F3C9A62AC82

P921

Q35185929-FEC0E0AE-D178-4FFB-9116-666B04118444

P932

Q35185929-F59E85FD-0FF4-4226-8D7C-62132DBB18B7

P1433

Genes & Development

P1476

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

@en

P2093

A L Kung

http://www.w3.org/2001/XMLSchema#string

C A Sieff

http://www.w3.org/2001/XMLSchema#string

D M Livingston

http://www.w3.org/2001/XMLSchema#string

L E Ch'ng

http://www.w3.org/2001/XMLSchema#string

R T Bronson

http://www.w3.org/2001/XMLSchema#string

T P Yao

http://www.w3.org/2001/XMLSchema#string

V I Rebel

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of c-MYC as a target of the APC pathway

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

The transcriptional coactivators p300 and CBP are histone acetyltransferases

The CBP co-activator is a histone acetyltransferase

RNA helicase A mediates association of CBP with RNA polymerase II

Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

P304

272-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10673499

http://www.w3.org/2001/XMLSchema#string

P921

P932

316359

http://www.w3.org/2001/XMLSchema#string